May 12th 2021, 9:00pm
By Kristie L. Kahl
In this edition of the Speaking Out video series, on behalf of the Head and Neck Cancer Alliance, CURE spoke with Dr. Michael Moore, from Indiana University School of Medicine about the basics of head and neck cancer.
May 12th 2021, 6:00pm
By Darlene Dobkowski, MA
According to a survey of 26 patients with advanced cancer, many reported that the U.S. opioid epidemic impacted their opinions of opioid use for pain management and conversations with their clinician regarding prescriptions.
May 12th 2021, 4:00pm
By Robin Zimmerman
A man who lost his wife to melanoma explains how he channeled his grief into advocacy that led to a change in legislation.
May 12th 2021, 3:00pm
By Colleen Moretti
Participants who ate 18 grams of mushrooms a day had a 45% lower risk of developing cancer compared to those who do not eat them.
May 12th 2021, 1:00pm
By Ryan McDonald
An analysis of more than 3.5 million children born between January 1996 and December 2016 demonstrated a stronger association between Down syndrome and acute myeloid leukemia risk than has been previously reported.
May 11th 2021, 9:00pm
The Geron Corporation announced that the first patient has been dosed with GRN163L — an experimental agent — in a phase 3 clinical trial to assess the drug’s overall survival benefit compared to best available therapy in patients with refractory myelofibrosis.
May 11th 2021, 6:00pm
Treatment with a novel therapy as a single agent, or in combination with Venclexta, demonstrated a manageable safety profile and antileukemic effects in patients with relapsed/refractory acute myeloid leukemia. The study authors, however, note that more research is needed.
May 11th 2021, 4:00pm
By Marissa Holzer
A woman with metastatic breast cancer describes the overwhelming dread she feels every time she must wait to hear the results of a tumor marker test.
May 11th 2021, 3:00pm
By Jessica Skarzynski
Prior to the program, patients with hematologic cancers walked an average of 136 steps in a 24-hour period. One month after the program began, that total increased to an average of 1,018 steps per day.
May 11th 2021, 1:00pm
Treatment with daily Jakafi and parsaclisib improved spleen volume reduction and symptom burden in patients with myelofibrosis who had previously failed to achieve significant response to single-agent Jakafi.
May 11th 2021, 12:45pm
By CURE Media Group
An expert in thoracic oncology, Adam J. Schoenfeld, MD, provides key insight into the use of cell therapy in non-small cell lung cancer after first-line treatment and highlights the potential for tumor-infiltrating lymphocyte (TIL) therapy depending on results from ongoing clinical trials.
May 10th 2021, 9:00pm
A gynecologic oncologist who has spent her career helping patients during their cancer journeys goes a step further to educate women on how to advocate for themselves and possibly prevent cancer before it occurs.
May 10th 2021, 6:00pm
On social media, CURE® recently asked its readers with rare cancers what advice they would offer to fellow patients with a similar diagnosis. Here’s what they shared.
May 10th 2021, 4:00pm
By Felicia Mitchell
Some experiences we have as cancer survivors may help inspire those reluctant to get or complete COVID-19 vaccinations to follow through. We are all role models for each other.
May 10th 2021, 3:00pm
Twenty percent of patients with resectable hepatocellular carcinoma had a significant amount of cell death when receiving Libtayo before surgical intervention.
Head and Neck Cancer: Self Exams, Vaccines, Treatment and More
New Trial to Find Biomarkers to Guide Treatment
GO2 Foundation Seeks to Better Understand Needs of People with Small Cell Lung Cancer
Vote for the 2021 Beacon of Hope Award Winner
